X
SYNH

Xponance’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Xponance’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,598
Closed -$531K – 1279
2023
Q2 		$531K Sell
12,598
-2,719
-18% -$110K 0.01% 887
2023
Q1 		$546K Sell
15,317
-299
-2% -$10.8K 0.01% 896
2022
Q4 		$573K Buy
15,616
+1,765
+13% +$69.8K 0.01% 850
2022
Q3 		$653K Sell
13,851
-147
-1% -$9.49K 0.01% 730
2022
Q2 		$1M Buy
13,998
+1,283
+10% +$93.8K 0.02% 572
2022
Q1 		$1.03M Sell
12,715
-199
-2% -$16.8K 0.02% 590
2021
Q4 		$1.33M Sell
12,914
-259
-2% -$24.9K 0.02% 504
2021
Q3 		$1.15M Buy
13,173
+17
+0.1% +$1.54K 0.02% 505
2021
Q2 		$1.18M Buy
13,156
+3,386
+35% +$286K 0.02% 522
2021
Q1 		$741K Buy
9,770
+903
+10% +$68.1K 0.02% 604
2020
Q4 		$604K Buy
8,867
+855
+11% +$53.3K 0.01% 657
2020
Q3 		$426K Buy
8,012
+1,496
+23% +$89.1K 0.01% 720
2020
Q2 		$380K Buy
+6,516
New +$350K 0.01% 738

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Xponance's SYNH Position: Q3 2023 in Review

Xponance sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 12,598 shares — an estimated $531K sold.

Xponance first reported a position in SYNH in Q2 2020 and held it in 13 quarters. The position peaked at $1.33M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Xponance reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Xponance sold 12,598 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $531K.
  • Xponance first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 13 quarters.
  • Xponance's Syneos Health, Inc. Class A Common Stock position peaked at $1.33M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Xponance's 13F filing for Q3 2023, filed 24 Oct 2023.